Amgen Inc. (BMV:AMGN)
Mexico
· Delayed Price · Currency is MXN 5,550.00
+66.00 (1.20%)
At close: Jul 8, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Prolia | 4.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prolia Growth | 8.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ENBREL | 3.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
ENBREL Growth | -11.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
XGEVA | 2.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
XGEVA Growth | 4.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nplate | 1.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nplate Growth | 1.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Aranesp | 1.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Aranesp Growth | -1.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Products | 5.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Products Growth | 20.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -0.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
KYPROLIS | 1.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
KYPROLIS Growth | 2.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Repatha | 2.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Repatha Growth | 33.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Otezla | 2.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Otezla Growth | -0.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EVENITY | 1.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EVENITY Growth | 33.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
BLINCYTO | 1.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
BLINCYTO Growth | 47.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vectibix | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vectibix Growth | 6.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TEZSPIRE | 972.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TEZSPIRE Growth | 68.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TEPEZZA | 1.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
KRYSTEXXA | 1.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
U.S. | 23.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
U.S. Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World (ROW) | 9.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World (ROW) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
McKesson Corporation Revenue | 22.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
McKesson Corporation Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue | 18.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardinal Health, Inc. Revenue | 11.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardinal Health, Inc. Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|